Breast cancer in young women - unique goals for treatment and research
Breast cancer that occurs in young women is likely to be more aggressive and to require more intensive types of therapy with increased risk of long-term treatment-related toxicities. The unique and significant challenges and psychosocial concerns that women under 40 years of age with breast cancer face are discussed in a special article published in Journal of Adolescent and Young Adult Oncology (JAYAO), a multidisciplinary peer-reviewed publication from, Mary Ann Liebert, Inc., publishers. JAYAO is the official journal of the Society for Adolescent and Young Adult Oncology. The article is available free on the JAYAO website until May 29th, 2015.
In the article “Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting”), the authors describe these young women affected by breast cancer as an “understudied population,” as they are under-represented in clinical trials. As a result, robust data on the biological, clinical, and psychosocial aspects of breast cancer in young women are lacking, and such data are needed to develop better interventions that can lead to improved patient outcomes.
###
Larissa A. Korde, MD, MPH, University of Washington, Seattle, Rebecca Johnson, MD, Mary Bridge Children’s Hospital, Tacoma, WA, Michelle Esser, Stacy Lewis, and Joy Simha, Young Survival Coalition, New York, NY, and Ann Partridge, MD, MPH, Dana Farber Cancer Institute, Boston, MA, provide a detailed summary of the information presented at the meeting of the Young Survival Coalition. They clearly present the Coalition’s priorities for research on breast cancer affecting young women, with the discussion and research goals focusing on six main areas: risk factors, treatment issues, fertility, pregnancy and breast cancer, quality of life and survivorship, and metastases.
About the Journal
Journal of Adolescent and Young Adult Oncology (JAYAO) is a quarterly peer-reviewed journal, published online with Open Access options and in print, dedicated to the promotion of interdisciplinary research, education, communication, and collaboration between health professionals in AYA oncology. JAYAO is the central forum for clinical, research, and professional specialties focused on improving cancer care and outcomes for AYA-aged cancer patients and survivors. Our multidisciplinary editorial board and readership includes but is not limited to: pediatric, medical, and surgical oncologists of all types and specialties; oncology nurses and advanced practice staff; psychosocial and supportive care providers, including psychiatrists, psychologists, and social workers; translational cancer researchers; and academic- and community-based pediatric and adult cancer institutions. Complete tables of content and a sample issue may be viewed on the Journal of Adolescent and Young Adult Oncology (JAYAO) website.
About the Society
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Palliative Medicine and Cancer Biotherapy and Radiopharmaceutials. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.
###
Vicki Cohn
.(JavaScript must be enabled to view this email address)
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Journal
Journal of Adolescent and Young Adult Oncology